Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Willem J M Dewilde"'
Autor:
Willem Lambertus, Bor, Anne Johanna Wilhelmina, de Veer, Renske H, Olie, Sem A O F, Rikken, Dean R P P, Chan Pin Yin, Jean Paul R, Herrman, Mathias, Vrolix, Martijn, Meuwissen, Tom, Vandendriessche, Carlos, van Mieghem, Michael, Magro, Naoual, Bennaghmouch, Rick, Hermanides, Tom, Adriaenssens, Willem J M, Dewilde, Jurriën Maria, Ten Berg
Publikováno v:
Eurointervention, 18(4), e303-e313. Europa Digital & Publishing
BACKGROUND: For patients with oral anticoagulants (OAC) undergoing percutaneous coronary intervention (PCI), European guidelines have recently changed their recommendations to dual antithrombotic therapy (DAT; P2Y12 inhibitor and OAC) without aspirin
Autor:
Daniel M F, Claassens, Pim W M, van Dorst, Gerrit J A, Vos, Thomas O, Bergmeijer, Renicus S, Hermanides, Arnoud W J, van 't Hof, Pim, van der Harst, Emanuele, Barbato, Carmine, Morisco, Richard M, Tjon Joe Gin, Folkert W, Asselbergs, Arend, Mosterd, Jean-Paul R, Herrman, Willem J M, Dewilde, Maarten J, Postma, Vera H M, Deneer, Jurriën M, Ten Berg, Cornelis, Boersma
Publikováno v:
American journal of cardiovascular drugs : drugs, devices, and other interventions. 22(2)
The POPular Genetics trial demonstrated that a CYP2C19 genotype-guided P2YIn this analysis, we aimed to evaluate the cost effectiveness of a genotype-guided strategy compared with standard treatment with ticagrelor or prasugrel.A 1-year decision tree
Autor:
Willem J M Dewilde, William F. McIntyre, Jeff S. Healey, Samantha Sartori, Satoshi Yasuda, Ashkan Shoamanesh, Renato D. Lopes, Stuart J. Connolly, Alexander P Benz, Isabelle Johansson, Nikolaus Sarafoff, Roxana Mehran, John W. Eikelboom
Publikováno v:
European heart journal. Cardiovascular pharmacotherapy. 8(7)
Aims The aim of this study was to systematically assess the effects of antiplatelets on clinical outcomes in patients with atrial fibrillation (AF), treated and not-treated with oral anticoagulation. Methods and results We searched MEDLINE, Embase, a
Autor:
Daniel M F, Claassens, Gerrit J A, Vos, Thomas O, Bergmeijer, Renicus S, Hermanides, Arnoud W J, van 't Hof, Pim, van der Harst, Emanuele, Barbato, Carmine, Morisco, Richard M, Tjon Joe Gin, Folkert W, Asselbergs, Arend, Mosterd, Jean-Paul R, Herrman, Willem J M, Dewilde, Paul W A, Janssen, Johannes C, Kelder, Maarten J, Postma, Anthonius, de Boer, Cornelis, Boersma, Vera H M, Deneer, Jurriën M, Ten Berg
Publikováno v:
The New England journal of medicine. 381(17)
It is unknown whether patients undergoing primary percutaneous coronary intervention (PCI) benefit from genotype-guided selection of oral P2YWe conducted a randomized, open-label, assessor-blinded trial in which patients undergoing primary PCI with s
Autor:
Willem J M, Dewilde, Paul W A, Janssen, Freek W A, Verheugt, Robert F, Storey, Tom, Adriaenssens, Morten L, Hansen, Morten, Lamberts, Jurriën M, ten Berg
Publikováno v:
Journal of the American College of Cardiology. 65(5)
Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review
Autor:
Willem J M, Dewilde, Paul W A, Janssen, Freek W A, Verheugt, Robert F, Storey, Tom, Adriaenssens, Morten L, Hansen, Morten, Lamberts, Jurriën M, Ten Berg
Publikováno v:
Journal of the American College of Cardiology. 64(12)
Chronic oral anticoagulant therapy is recommended (class I) in patients with mechanical heart valves and in patients with atrial fibrillation with a CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, prior Strok
Autor:
Willem J M, Dewilde, Tom, Oirbans, Freek W A, Verheugt, Johannes C, Kelder, Bart J G L, De Smet, Jean-Paul, Herrman, Tom, Adriaenssens, Mathias, Vrolix, Antonius A C M, Heestermans, Marije M, Vis, Jan G P, Tijsen, Arnoud W, van 't Hof, Jurriën M, ten Berg, K, Cornelis
Publikováno v:
Lancet, 381(9872), 1107-1115. Elsevier Limited
LANCET, 381(9872), 1107-1115. ELSEVIER SCIENCE INC
The Lancet (London), 381, 9872, pp. 1107-15
The Lancet (London), 381, 1107-15
LANCET, 381(9872), 1107-1115. ELSEVIER SCIENCE INC
The Lancet (London), 381, 9872, pp. 1107-15
The Lancet (London), 381, 1107-15
Item does not contain fulltext BACKGROUND: If percutaneous coronary intervention (PCI) is required in patients taking oral anticoagulants, antiplatelet therapy with aspirin and clopidogrel is indicated, but such triple therapy increases the risk of s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb48d33e467827af22b5fe98e14210f8
https://pure.amc.nl/en/publications/use-of-clopidogrel-with-or-without-aspirin-in-patients-taking-oral-anticoagulant-therapy-and-undergoing-percutaneous-coronary-intervention-an-openlabel-randomised-controlled-trial(4a641e62-b0ac-4bdb-b43a-7b9a15f470d5).html
https://pure.amc.nl/en/publications/use-of-clopidogrel-with-or-without-aspirin-in-patients-taking-oral-anticoagulant-therapy-and-undergoing-percutaneous-coronary-intervention-an-openlabel-randomised-controlled-trial(4a641e62-b0ac-4bdb-b43a-7b9a15f470d5).html